Obesity in schizophrenia: Screening, monitoring, and health promotion

Perspectives in Psychiatric Care

Volumn 44, Issue 1, 2008, Pages 25-31

  Beebe, Lora Humphrey ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Antipsychotic medications; Lifestyle interventions; Obesity; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; LIFESTYLE; MASS SCREENING; METHODOLOGY; OBESITY; PATIENT EDUCATION; RISK FACTOR; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; LIFE STYLE; MASS SCREENING; OBESITY; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SCHIZOPHRENIA;

EID: 37649019163     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2008.00144.x     Document Type: Article

References (38)

1. Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Capelleri, J. C., Chandler, L. P., et al 1999). The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry, 60, 215 220.
2. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity 2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596 601.
3. Ball, M. P., Coons, V. B. Buchanan, R. W. (2001). A program for treating olanzapine related weight gain. Psychiatric Services, 52 (7), 967 969.
4. Bandura, A. (1995). Self-efficacy in changing societies. New York : Cambridge University Press.
5. Beebe, L. H. (2005). Describing the health parameters of outpatients with schizophrenia. Applied Nursing Research, 19, 43 47.
6. Beebe, L. H. (2006). Walking Tall: A person with schizophrenia on a journey to better health. Journal of Psychosocial Nursing, 44 (6), 53 55.
7. Beebe, L. H., Tian, L., Morris, N., Goodwin, A., Allen, S. Kuldau, J. (2005). Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues in Mental Health Nursing, 26 (6), 661 676.
8. Blackburn, G. L. (1995). Effect of degree of weight loss on health benefits. Obesity research, 3 (Suppl. 2 211S 216S.
9. Centers for Disease Control Prevention 2006). Defining overweight and obesity. Retrieved November 28, 2006, from http://www.cdc.gov/nccdphp/dnpa/ obesity/defining.htm
10. Chamove, A. S. (1986). Positive short-term effects of activity on behavior in chronic schizophrenic patients. British Journal of Clinical Psychology, 25, 125 133.
11. Cormac, I. Ferriter, M. (2006). The physical health care of psychiatric patients in adult mental health services. The Mental Health Review, 11 (1), 21 26.
12. Daly, P. A., Solomon, C. G. Manson, J. E. (Eds.) (1996). Risk modification in the obese patient. New York : Oxford University Press.
13. Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., et al 2000). Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin, 26, 903 912.
14. Dixon, L. B. (2003). Diabetes and mental illness: Factors to keep in mind. Consultant, 43 (3), 337 348.
15. Evans, S., Newton, R. Higgins, A. (2005). Nutritional intervention to prevent weight gain in inpatients commenced on olanzapine: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 39, 479 486.
16. Ganguli, R. (2002). Rationale and strategies for switching antipsychotics. American Journal of Health & Systems Pharmacology, 59, S22 S26.
17. Gimino, F. A. Levin, S. J. (1984). The effects of aerobic exercise on perceived self-image in post-hospitalized schizophrenic patients. Medicine and Science in Sports and Exercise, 16, 139.
18. Green, A. I., Patel, J. K., Goisman, R. M., Allison, D. B. Blackburn, G. (2000). Weight gain from novel antipsychotic drugs: Need for action. General Hospital Psychiatry, 22, 224 235.
19. Harris, E. C. Barraclough, B. (1998). Excess mortality of mental disorder. British Journal of Psychiatry, 173, 11 53.
20. Jessup, J., Lowenthal, D., Pollock, M. Turner, T. (1998). The effects of endurance exercise on ambulatory blood pressure in older normotensive adults. Geriatric Nephrology and Urology 0), 1 7.
21. Kaur, G. Kulkarni, S. K. (2003). Involvement of normal physiological mechanisms in mediation of satiety by polyherbal antiobesity preparation, OB-200G, in female mice. Methods and Findings in Experimental and Clinical Pharmacology, 25 (1), 33 39.
22. Littrell, K. H., Hilligoss, N. M., Kirshner, C. D., Petty, R. G. Johnson, C. G. (2003). The effects of an educational intervention on antipsychotic induced weight gain. Journal of Nursing Scholarship, 35 (3), 237 241.
23. Masand, P. S. (2005). A review of pharmacologic strategies for switching to atypical antipsychotics. Journal of Clinical Psychiatry, 7 (3), 121 129.
24. Masand, P. S., Blackburn, G. L., Ganguli, R., Goldman, L. S., Gorman, J., Greenberg, I., et al 1999). Weight gain associated with the use of antipsychotic medications. Journal of Clinical Psychiatry [Audiograph series], 2.
25. McEvoy, J. P. (2002, May). The impact of safety and tolerability on patient's satisfaction with therapy. In D. O. Perkine (Chair Challenges and opportunities in the management of psychotic disorders. Symposium presented at the Annual Meeting of the American Psychiatric Association, Philadelphia.
26. Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D. R. Sakowitz, M. (2004). Managing atypical antipsychotic associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry, 65 (4), 471 477.
27. Meyer, J. M. Koro, C. E. (2004). The effects of antipsychotic therapy on serum lipids: A comprehensive review. Schizophrenia Research, 70, 1 17.
28. Meyer, J. M., Nasrallah, H. A., McEvoy, J. P., Goff, D. C., Davis, S. M., Chakos, M., et al 2005). The Clinical Antipsycotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia Research, 80, 9 18.
29. Mitchell, A. J. Malone, D. (2006). Physical health and schizophrenia. Current Opinions in Psychiatry, 19, 432 437.
30. National Cholesterol Education Panel 2002). Third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 106, 3143 3421.
31. Peet, M. (2004). Diet, diabetes and schizophrenia: Review and hypothesis. British Journal of Psychiatry, 184 (Suppl. 47 s102 s105.
32. Pelham, T. W., Campagna, P. D., Ritvo, P. G. Birnie, W. A. (1993). The effects of exercise therapy on clients in a psychiatric rehabilitation program. Psychosocial Rehabilitation Journal, 16, 75 84.
33. Ryan, M. C., Collins, P. Thakore, J. H. (2003). Impaired fasting glucose tolerance in first episode, drug naïve patients with schizophrenia. American Journal of Psychiatry, 160 (2), 284 289.
34. Stokes, C. Peet, M. (2003). Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutrition and Neuroscience, 7 (4), 247 249.
35. U.S. Department of Health Human Services, Centers for Disease Control Prevention, National Center for Chronic Disease Prevention Health Promotion 1996). Physical activity and health: A report of the surgeon general. Atlanta, GA : Author.
36. Van Gaal, L. F. (2006). Long term health considerations in schizophrenia: Metabolic effects and the role of abdominal adiposity. European Neuropsychopharmacology, 16 (Suppl. 3 S142 S148.
37. Vreeland, B., Minsky, S., Menza, M., Rigussio-Radler, D., Roemheld-Hamm, B. Stern, R. (2003). A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services, 54 (8), 1155 1157.
38. Weiden, P. J., Simpson, G. M., Potkin, G. G. O'Sullivan, R. L. (2003). Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. Journal of Clinical Psychiatry, 64, 58.